chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, neck ache, body aches 24 hours in duration .  Sore left arm 96 hours in duration.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients who on an unknown date, could have either been administered with a doses of VAQTA (doses, routes and lot numbers not reported) that were exposed to temperature conditions that we could not support. No adverse reactions were reported. Attempts are being made to obtain additional information identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports from the same source. Additional information has been requested.
Expired dose used ( BEXSERO); This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA82AA, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd February 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 2nd February 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received expired dose of Bexsero, which led to expired vaccine used. The reporter consented to follow up.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided. No treatment information was provided.  Reporter stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
3RD DOSE MODERNA COVID VACCINE GIVEN 11/23/21, #066F21A 4TH DOSE MODERNA COVID VACCINE GIVEN 5/19/22, #004321A pt to hospital from SNF with SOB and hives; Atrial fibrillation with RVR; given Cardizem and started on Heparin drip; worsening mental status and metabolic acidosis; transitioned to comfort care and pt passed away in the hospital
received menveo with sterile water; received menveo with sterile water; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA591A, expiry date 31st August 2022) for prophylaxis.   On 21st March 2022, the patient received Menveo. On 21st March 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: The health care professional (HCP) reported that on the day of reporting, the patient received the lyophilized portion of Menveo with sterile water, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. No reactions reported. The Vaccine Administration Facility was the same as primary reporter. The reporter consented to follow up by email.
I felt fatigued, tired , no appetite and ran low grade fever starting the evening after vaccination.   This continued with dry heaves, poor appetite and vomiting Sunday and Monday.   Tuesday evening I ran fever of 102.4, took Tylenol and promptly vomited.  Then I noticed my heart racing.  Took my BP which was 107/60 and hear rate 150s.   I had my brother take me to the Medical Center where I was admitted for observation.     I was told the I was in A Fib with rapid ventricular response.   I was given 15 mgm of dialtizem IV x two, one liter of IVF and then converted to NSR.  I was admitted overnight for observation
Red swollen area to L elbow, warm to touch, c/o abdominal pain/ distention- this was his 2nd Booster dose; no other vaccines were given one month prior to the date of this vaccine.
Patient stated she felt highly inebriated.  She said it took all of her concentration to talk clearly.  The onset was approximately one and one-half hours post administration.  She had no swelling of tongue, face, or throat.  No problems with breathing or airway constriction.  Patient had not eaten all day before the immunization even at the time we spoke on the phone.  I asked her to go to the emergency room.  She wanted to delay.  I called her back 45 minutes later. The patient had eaten and had a beverage.  She said all symptoms had gone away except she felt a bit tired.  I discouraged her from receiving the next dose.
About 15-20 minutes after the injection, I had tingles in my arms and torso.  The nurse on duty suggested I take an anti-histamine, which I did.  These tingles lasted about 1-2 hours; I went on the treadmill and they went away. But the next day, I was very fatigued, and slept a lot, and when I got up at various times I experienced a feeling of dizziness or vertigo.  Mild, but definitely there.   Arm soreness as per usual.   That's all.
Symptoms started on Saturday, April 20. Body aches, joint pain, nausea, chills, low-grade fever, headache, loss of appetite, Extreme pain.
Patient started feeling dizzy, malaise and then patient had a syncope event where he also started having uncontrollable movements.
Patient is a 82 year old male,  has a past medical history of Hypertension and Parkinsons..  Presents with persistent shortness of breath, associated with weakness, cough.  Symptoms have been ongoing for the last week or so, presented to his primary care physician's office on July 19, received a nebulizer, IV Solu-Medrol 125, was swabbed for COVID-19 despite being vaccinated, and was resulted as negative.  However he has been unsteady, and was unable to get out of the bed, and was brought to the ER.  Tested positive for coronavirus during admission in the setting of chronic dsypnea on exertion.  He was discharged off supplemental oxygen and tolerating room air.
About 9/15/2021 and 9/16/2021, which is about 5 to 6 days after I received the first dose of the Pfizer Covid vaccine, I started having mild pain in my chest around the heart. This pain is more noticeable when I lie down or when I take deep breath or fast breath. If I bend my body down like to pick something from the floor, I hear some internal grumbling around my chest. I also have some burning sensation around my heart area. I was thinking this pain will go away in a couple of days but still remain till the time of filing this report, 9/27/2021.
Petechial rash throughout body, mother saw wheals that quickly resolved. One episode of apnea (she was having these before).
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient presented 2 days after injection with mild swelling , redness and pain at injection site.   Site was hard and warm to the touch  .. Suggested patient see physician to ascertain either allergic reaction or infection at injection site
This case was reported by a consumer via call center representative and described the occurrence of axillary pain in a 72-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date). Concurrent medical conditions included chronic lymphocytic leukemia (diagnosed in December 2017). On 19th July 2018 09:30, the patient received the 2nd dose of SHINGRIX (intramuscular). In July 2018, 1 day after receiving SHINGRIX, the patient experienced axillary pain. On an unknown date, the outcome of the axillary pain was unchanged. It was unknown if the reporter considered the axillary pain to be related to SHINGRIX. Additional details were provided as follows: The patient received dose of SHINGRIX in the left arm. The patient stated that a day after getting the shot of SHINGRIX vaccine, she experienced tenderness in her arm pits. Her condition was still unchanged. The patient had denied permission to contact their physician. No further details were provided by the patient. The patient was referred to her physician.
onset of vomiting approx 8 hrs recvd vax; vomited x 5; also had inc t102; temp dec to 100 in 24 hrs; also c/o aching, chills & h/a; erytheam & swelling @ inject site;
This case was reported by a pharmacist via call center representative and described the occurrence of seizure in a 68-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020) for prophylaxis. On 4th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In May 2018, 14 days after receiving SHINGRIX, the patient experienced seizure (serious criteria hospitalization and GSK medically significant), confusion (serious criteria hospitalization), swelling arm and feeling hot. On an unknown date, the outcome of the seizure, confusion, swelling arm and feeling hot were recovered/resolved. It was unknown if the reporter considered the seizure, confusion, swelling arm and feeling hot to be related to SHINGRIX. Additional details were provided as follows: The patient received the vaccine on the left arm. The pharmacist reported that the patient experienced swelling in the left arm. The patient was hospitalized for confusion and seizure.
9/18/2021 tested positive for COVID-19 via PCR; developed pneumonia, fever, chills, myalgia, sore throat, headache, cough, dyspnea, abdominal pain, congestion, bloody stool, weakness;
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in her feet and ears), THROAT IRRITATION (Burning in throat), CHEST PAIN (Burning in chest), DIZZINESS (Slight lightheadedness) and EAR DISORDER (Ears with sensation of fullness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Jan-2021, the patient experienced PRURITUS (Itching in her feet and ears), THROAT IRRITATION (Burning in throat), CHEST PAIN (Burning in chest), DIZZINESS (Slight lightheadedness) and EAR DISORDER (Ears with sensation of fullness). At the time of the report, PRURITUS (Itching in her feet and ears), THROAT IRRITATION (Burning in throat), CHEST PAIN (Burning in chest), DIZZINESS (Slight lightheadedness) and EAR DISORDER (Ears with sensation of fullness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Very limited information regarding these events has been provided at this time.  Further information has been requested. Reporter did not allow further contact; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested
Pt rec'd Zostavax, that night pt developed pain under her skin all over her body, began in chest and upper bod and spread.  Eye sockets hurt a lot as if she had a high fever.  Vision was normal.  Ached all over when touched any part of body.  No rash, no fever, no GI symptoms; lasted one week then gradually subsided.
Seen 8/29/07 for urticaria. Had Prevnar 2d before on 8/27/07. Per mom had a flat red rash 2d after Prevnar on 5/22/07. Possible allergy ---> to allergist to confirm.
fever of 99.7; bones are inflamed and flushed; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 99.7), OSTEITIS (bones are inflamed and flushed) and PAIN (body aches) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PYREXIA (fever of 99.7), OSTEITIS (bones are inflamed and flushed) and PAIN (body aches). At the time of the report, PYREXIA (fever of 99.7), OSTEITIS (bones are inflamed and flushed) and PAIN (body aches) outcome was unknown.
A pediatrician has reported that a white female child received his 1st dose of Prevnar. The date of Prevnar administration and any concomitant vaccines were not reported. On an unspecified date, the child experienced a systemic rash. No further information was available at the date of this report. Followup information has been received on 5 OCT 2001 from the initial reporter concerning the 4 month old female child (age/gender clarified). On 16 AUG 2001, the child received her first injection. The chold received no concomitant vaccines and was taking no other medications. Four days later, on 20 AUG 2001, the child experienced a systemic rash. The child has recovered.
When I received my COVID vaccine, there was some overspill of the vaccine and blood that spilled out of the injection site. The vaccinating RN told me to put some pressure on it. And to monitor the site for more bleeding. I received the vaccine around 09:00. Around 15:00, I took off my bandaid to check the site, and I noticed that I now have a bump at the injection site. It is not a large bump, about 1 cm in diameter. The bump is subcutaneous, I cannot see it from the surface, but I feel it.
I started to feel flu like symptoms. I stood up to get out the bath and felt fatigue and vision became blurry. I had laid on back; and my arm and feet started to  feel like Charlie-horse. It was very hard to speak. My words became slurred as I was speaking. I felt like I was having heart attack.  I had the worst flu symptoms for about 2 days and symptoms went away.
rash/rash on her right leg; This is a spontaneous report from a contactable consumer (Patient). A 66-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6204, Expiry date was not reported), via an unspecified route of administration on 10Mar2021 09:00 (at the age of 66-years-old) in Arm Left as dose 1, single for COV1ID-19 immunization. The Patient Medical history included kidney disease from 2017 to an unknown date, blood pressure abnormal from an unknown date and unknown if ongoing, diabetes mellitus from an unknown date and unknown if ongoing, high blood pressure from an unknown date and unknown if ongoing and other Conditions also on dialysis. Concomitant medication(s) included glipizide (GLIPIZIDE) taken for diabetes mellitus from an unspecified start date and ongoing taking 6 months; furosemide (LASIX [FUROSEMIDE]) taken for hypertension from an unspecified start date and ongoing taking for 6 months; doxazosin (DOXAZOSIN) taken for blood pressure abnormal from an unspecified start date and ongoing taking for a month; olmesartan (OLMESARTAN) taken for blood pressure abnormal from an unspecified start date and ongoing taking for 6 months; carvedilol (CARVEDILOL) taken for blood pressure abnormal from an unspecified start date and ongoing taking for 6 months; amlodipine (AMLODIPINE) taken for blood pressure abnormal from an unspecified start date and ongoing taking for 6 months. History of all previous immunization with the Pfizer vaccine considered as suspect was none and additional Vaccines Administered on Same Date of the Pfizer Suspect was none. The patient had not received prior vaccinations within 4 weeks. Patient had no illness at the time of vaccination. Caller is 66 y/o (year-old) female. States she has already spoke with someone at Pfizer and reported her AE. Will e-transmit as duplicate AE. She received first dose of Pfizer Covid vaccine on 10Mar2021. On 11Mar2021, she states she developed a rash on her right knee that does down to her right calf. She wants to know if we have any guidance for this. Consumer calling regarding the Pfizer Covid-19 vaccine. States she developed something on her leg, very distinctly like a design on her right leg below the knee, like a pattern, and it doesn't hurt. She got the vaccine yesterday and then noticed this today. She would like to ask a professional about it. Clarifies she received the first dose of the Pfizer Covid-19 vaccine 10Mar2021 at 09:00a.m. in the left arm. Noticed the rash on her leg today 11Mar2021. Since she noticed it it has not changed. The patient was not visited to physician or emergency room. The Patient had no relevant test. The outcome for the event rash on her right leg was not recovered.  No follow-up attempts are possible. No further information is expected.
Headache, Myalgia, Arthralgia, ARM PAIN, FATIGUE Narrative:
Six patients received expired Moderna vaccine booster shots after 30-day Use By Date / after manufacturer date of expiry.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Six patients received expired Moderna vaccine booster shots after 30-day Use By Date / after manufacturer date of expiry.) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Six patients received expired Moderna vaccine booster shots after 30-day Use By Date / after manufacturer date of expiry.). On 27-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Six patients received expired Moderna vaccine booster shots after 30-day Use By Date / after manufacturer date of expiry.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Products were reported. No Treatment information was reported.   This case was linked to MOD-2021-429306 (Patient Link).
Arthralgia, Fatigue, chills, injection site pain and tenderness Narrative:
Rash appeared on right arm approximately 7 days after receiving the vaccine. Rash has persisted for 6 days so far.
Soreness in left arm for 5 weeks after administration of flu vaccine. Presents to pharmacy on 11/18/19 complaining of continuing soreness and pain when raising arm past shoulder
4 days after shot, started with welp on inside of right leg, by evening severe rash around waist, under arms, on back and at  back of legs at top. Very itchy with raised welps.  Lasted  until evening of Feb 5 after taking benadryl.
I got my period within a few days after getting the 2nd shot, which was 15 days earlier than my normal cycle. Since then, my period cycle has shifted from end of month to mid month. I started getting very painful cramps. They feel like knives stabbing at my pelvic area. Twice I have been so fatigued that I can't do anything but lie down for 24 hours. This is something I have never experienced, and only started experiencing after getting the vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weaknness feeling) and DIZZINESS (Suffering Dizzines) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.  No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weaknness feeling) and DIZZINESS (Suffering Dizzines). At the time of the report, ASTHENIA (Weaknness feeling) and DIZZINESS (Suffering Dizzines) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Concomitant medication was reported No treatment Drug was reported Reporter did not allow further contact
Area below injection site reddened and warm to the touch.  Flu Shot given on 10/03/2016, Arm red and swollen on 10/04/2016.  Employee sent to clinic for evaluation and was diagnosed with an allergic reaction.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Additional Details: I administered the vaccine and the patient sat for 15 minutes with her young daughter. At the end of the 15 minutes I asked if she was ok and she said she was and walked off.  Less than 5 minutes later I hear a smack like someone smacking a concrete floor with their bare hand and see her feet in the air and she is laying face down. She sits right up and is pale and confused but responsive.  I immediated called EMTs and the fire department arrived and took her to the hospital.  Prognosis unknown
Patient had "extreme" fever and chills at 9:30 pm after receiving vaccine. She complained that she woke up every 3 hours and needed to use several blankets for chills. At 5:30 am patient woke up soaked and sheets were soaked. At this time fever gone, but feeling weak.
Extreme fatigue, vomiting, ache, headache, joint pain, chills with hot spells, lack of appetite. This is from the 2nd vaccination which occurred April 11th. Vomiting lasted for two days, aches are now less and fatigue is better but still lingering towards end of day. Appetite returned approx. April 18th.
Information has been received regarding a case in litigation from a lawyer, a patient of unknown age and gender, and the spouse of the patient. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 07-DEC-2016, at age 59, the patient was administered the ZOSTAVAX by a pharmacist at a pharmacy. On an unknown date, the patient was treated by a physician for the following injury resulting from the patient's ZOSTAVAX use: Shingles. The outcome of the shingles is unknown. The patient claims damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. Additional information has been requested.
shortness of breath Narrative:  Pt experienced nauseau and shortness of breath one week after vaccination. Wife states that patient is currently hospitalized and he was found to have blood clots in lungs after holding Xarelto for a steroid injection. Outside provider deemed that this problem is most likely un-related due to COVID-19 Vaccine. Patient is still expected to get second dose of COVID-19 vaccine. Followed up with anticoagulation clinic
COVID-19 I tested positive on July 8, 2022 I  experienced sore throat, chills, cough, shortness of breath, could not  walk or talk. I was taken to the hospital by ambulance for treatment, I was given Remdesivir for my symptoms. I was also on a bipap for my breathing. Still feel a little tired sometimes and also has brain fog.